An essential property of microbial communities is the ability to survive a disturbance.
Introduction
A disturbance is a biological, chemical, or physical event that affects a community 1 . Given that the environment is constantly changing, an essential property of a community is its ability to recover after being disturbed. Responses to a disturbance include resistance, the ability to withstand perturbation in the presence of a disturbance; resilience, the ability to recover after being perturbed by a disturbance; or sensitivity, the inability to withstand or recover from a disturbance [2] [3] [4] [5] . Resistance and resilience have been documented in a range of systems and are often determined by different processes 1, 2, 5, 6 . Specifically, resistance is associated with processes that enable the tolerance of, or adaptation to, a disturbance, whereas resilience is associated with recolonization, reproduction, or rapid regrowth 2 . The ability to identify the determinants for resistance versus resilience is crucial for predicting how a given community will respond to a disturbance as well as for designing strategies that will either preserve, change, or eliminate it 3, 4, 7 . Although resistance and resilience have been defined in the literature for decades 8 , the resistance-resilience framework has not been widely applied. This is partially because it is often difficult to determine the predisturbance state of a population, the definitions vary, and there is a lack of quantitative studies demonstrating how to implement these terms 2, 4, [9] [10] [11] [12] .
Yet, this resistance-resilience framework naturally lends itself to the analysis of bacterial responses to antibiotic treatment. When running susceptibility tests, it is possible to characterize a pre-disturbance state (i.e. no exposure to antibiotic) and there are many ways to quantify the bacterial antibiotic responses (i.e. agar plates, E-test, plate reader, microscopy) [13] [14] [15] . Until now, resistance and resilience have not been distinguished in the context of antibiotic responses. Instead, bacteria are classified as resistant if they survive exposure to a set concentration of antibiotic after a set amount of time 16, 17 (Table 1) . However, the apparently similar survival can result from diverse underlying mechanisms [18] [19] [20] [21] [22] that can lead to the ability of individual cells to withstand the treatment or the ability of the population to recover from the initial disturbance. We term the former resistance and the latter resilience.
Here, we apply these concepts to the analysis of bacterial pathogens producing extended spectrum β-lactamases (ESBLs), which are becoming increasingly prevalent and can degrade many β-lactam antibiotics -the most widely used class of antibiotics in the clinics [23] [24] [25] [26] [27] . On one hand, our results offer new insights into the design of antibacterial treatment strategies against one of the fastest-rising types of bacterial pathogens [28] [29] [30] . In particular, the resistance-resilience framework reveals the phenotypic signatures of different ESBL-producing bacteria and underscores the critical need to implement adjustable formulations of combination treatments. On the other, the framework we illustrate here is generally applicable for the analysis of bacterial populations to any environmental perturbations.
Results

Temporal dynamics of ESBL-producing bacteria in response to β-lactam treatment
The dynamics of an ESBL-producing population are uniquely suited for illustrating resistance and resilience during disturbances. In the absence of antibiotic treatment, the population grows approximately exponentially before reaching the stationary phase, upon depletion of nutrients ( Figure 1A) . Thanks to the expression of a β-lactamase (Bla) anchored in their periplasm, these bacteria can degrade antibiotic that diffuses across the outer membrane 31 . However, if Bla expression is moderate, these bacteria can still be lysed by a β-lactam antibiotic at a sufficiently high concentration ( Figure 1B) . As this occurs, Bla is released into the environment due to membrane leakage (from a cell not-yet lysed) or cell lysis 32 . If sufficient Bla (periplasmic and extracellular) is present, the antibiotic is degraded in time for the population to recover before all cells are lysed. A population's recovery depends on collective tolerance (Supplementary Fig. 1 ):
it must have a sufficiently high density when treated so enough Bla is collectively produced to remove the antibiotic before all bacteria are lysed. If the initial density is too low, then insufficient Bla will be produced to protect the population from antibiotic exposure.
Here, we showed that the population recovery was indeed due to the Bla degrading the antibiotic, indicated by the level of antibiotic activity in the supernatant after 6 hours of exposure ( Figure 1C) . Sensitive bacteria do not produce Bla and cannot break down the antibiotic, thus the antibiotic remaining in the supernatant could inhibit the growth of sensitive bacteria. At a higher initial antibiotic concentration, the same amount of supernatant generated a larger zone of inhibition. In contrast, the bacteria producing ESBLs sufficiently degraded the antibiotic at both doses during the incubation period, as evidenced by the inability of the resulting supernatants to inhibit growth of sensitive cells.
To test if the population recovery was due to the selection of a more resistant or resilient subpopulation, we collected ESBL producing bacteria that had recovered from an antibiotic treatment and re-exposed them to a range of antibiotic concentrations. The resulting antibiotic responses were similar, regardless of previous exposure concentrations ( Figure 1D ). This shows that the recovery was not due to the selection of a sub-population with enhanced tolerance, which is consistent with the notion of antibiotic degradation due to the Bla released from cell lysis.
We also tested if the antibiotic induced the production of Bla by using Fluorocillin, a substrate that fluoresces green when degraded by Bla, allowing for the real-time visualization of Bla activity. After incubating the isolate with different concentrations of cefotaxime for 3 hours,
we added Fluorocillin to the sonicated culture to quantify the total Bla present. There was no significant increase in fluorescence as a function of antibiotic concentration ( Figure 1E ) at the p 
Defining resistance and resilience
A population can survive a disturbance due to its resistance or resilience 1, 2, 9 . In general, resistance refers to the ability of a population (or a community) to withstand the disturbance, whereas resilience refers to the ability to recover after suffering from the disturbance. Both properties are evident in the temporal dynamics of an ESBL-producing population in response to β-lactam treatment (Figure 1) . Here, we quantify resistance as the ability of the population to not deviate from the pre-antibiotic-treatment state (as quantified by the growth rate). Mathematically, we define resistance at the time of maximum change in a treated population's net growth rate (ρA) normalized by the untreated population's net growth rate at the same point in time (ρ0). When dealing with the experimental data, our analysis accounts for the time delay in lysis caused by a β-
By this definition, resistance primarily reflects the instantaneous response of individual cells, but manifested at the population level. In particular, the magnitude of the metric depends on the probability by which an average bacterium is lysed by the antibiotic. This probability is directly determined by the expression level and activity of Bla in the bacterium, as well as the extracellular concentration of the antibiotic. In our analysis, we use optical density (OD) as a measure of the cell density.
We quantify resilience as the rate of recovery by the population after experiencing the initial crash (Figure 1) , by using the time needed for a population to reach 50% of its carrying capacity (T 50% ). With increasing antibiotic concentration, more cells will lyse in the process of degrading the antibiotic, thus increasing the resulting recovery time. The more resilient a population is, the faster it can return to a normal state after being perturbed by an antibiotic. We define resilience as the inverse of the treated population's T 50% ( 50% ), normalized by the untreated population's T 50% ( 0 50% ) (Figure 2A-B, Supplementary Fig. 2 ) 1 . The inverse is taken to reflect the fact that increasing the recovery time corresponds to a decrease in resilience.
By this definition, resilience reflects a long-term response and primarily depends on population-level traits: when a single bacterium can no longer survive the effects of antibiotic, the population is initially impacted; however, collective antibiotic tolerance can allow for the population to outlast the disturbance and recover after being perturbed.
For each bacterial strain, the degree of resistance or resilience depends on the type and dose of antibiotic used. At low antibiotic concentrations, the population experiences little or no disturbance and thus is characterized with relatively high resistance and resilience ( Figure 2C ).
At intermediate concentrations (A=1.5 μg/mL), the population's recovery displays a decline in both resistance and resilience because the antibiotic concentration is high enough to induce some lysis and slow the net growth rate and delay the recovery time. Once the antibiotic concentration is high enough to induce a population crash (A>5 μg/mL), the recovery of the population shifts to being dominated by resilience. If the antibiotic concentration exceeds the threshold for population recovery, the resulting resilience and resistance will be minimal. This resistance-resilience framework effectively reveals the phenotypic signature of each strain ( Figure 2D ) when treated by a β-lactam.
In our experiments, the OD values are sufficiently small such that they are proportional to the total biomass 33 . Debris from lysed cells can also contribute to the OD values. However, this contribution is negligible except for OD values that are near the baseline (when cells are lysed).
As such, it has negligible impact on calculated values of resistance or resilience.
Determinants of resistance and resilience
To help further our investigation, we developed a kinetic model to describe the temporal response of a bacterial population constitutively expressing Bla to a β-lactam antibiotic. When no antibiotic is present, the population grows to carrying capacity without delay; however, once the antibiotic concentration is high enough, the population density undergoes a crash as a significant portion of the population is lysed by the antibiotic, and a recovery, as the released Bla degrades the antibiotic ( Figure 3A, Supplementary Fig. 3 ). We chose to simplify the system by lumping the activity of intra-and extra-cellular Bla, based on direct measurements that suggest that extracellular Bla plays a much greater role once significant lysis has occurred ( Supplementary Fig. 4 ).
Global sensitivity analysis was used to determine which parameters influenced resistance and resilience under a range of antibiotic concentrations. Briefly, the Sobol method calculates resilience and resistance for a range of parameter values and breaks down the variation for each into fractions that can be attributed to one or more parameters 34 . Here, we reported the total effect index, ST, which reflects how much a parameter and all its interactions with any other parameters contributes to the variation in resistance and resilience at a particular antibiotic concentration ( Figure 3B, Supplementary Fig. 5 ). Comparing the ST for each parameter when A=100 μg/mL reveals that resistance is only sensitive to the maximum lysis rate (S = 1±0.02). The sensitivity analysis revealed that all parameters affect resilience to varying degrees, depending on the antibiotic concentration. Resilience is sensitive to the maximum lysis rate (S = 0.9 ± 0.02), Bla activity (S = 0.13 ± 0.01), the turnover rate of Bla (S = 0.05 ± 0.003), and the amount of nutrients recycled from cell lysis (S = 0.03 ± 0.01). These parameters determine the collective ability of the population to remove the antibiotic, underscoring the notion that resilience is a population-level trait.
We tested the influence of Bla activity computationally by varying , and experimentally by using clavulanic acid, a well-characterized Bla inhibitor ( Figure 3C, Supplementary Fig. 6 ).
With increased Bla inhibition, the population became more sensitive to the antibiotic, thus resulting in the antibiotic response shifting from relying on both resistance and resilience to just resilience at a lower concentration of antibiotic. Furthermore, the population with significantly reduced Bla activity did not survive exposure to the higher concentrations of antibiotic (resistance and resilience were both reduced).
Phenotypic signatures of bacterial responses in the resistance-resilience framework
Given that Bla inhibitors are commonly used to restore sensitivity to some β-lactam antibiotics 31 , we explored the implications of using the resistance-resilience framework to optimize combination treatments by analyzing the response of four different ESBL-producing isolates (Supplementary Table 1 ). We exposed each isolate to different combinations of antibiotic and Bla inhibitor concentrations and recorded their antibiotic responses. The resistance and resilience for each scenario were calculated and plotted against each other ( Figure 4A ). The framework revealed how a small dose of antibiotic (5 µg/mL cefotaxime) could minimize resistance for Isolate I, but larger doses were needed to minimize resilience. However, resilience could be minimized with a small dose of Bla inhibitor (0.05 µg/mL clavulanic acid), when in combination with the antibiotic. A similar trend was observed in Isolates II and IV, with treatments using higher concentrations of Bla inhibitor requiring less antibiotic to minimize resistance and resilience.
Isolate III, however, was not affected by increasing concentrations of Bla inhibitor, as seen by the overlapping resistance-resilience curves. Only the highest concentration of Bla inhibitor (0.5 µg/mL) in combination with a high concentration of antibiotic (150 µg/mL) prevented the population from recovering.
Using the resistance-resilience framework, we determined that the minimum inhibitory concentration (MIC) of antibiotic for each level of Bla inhibitor was unique for each isolate ( Figure 4B) . Here, the MIC is defined as the concentration necessary to prevent the population from recovering within 48 hours of being exposed to treatment. For example, when 0.05 µg/mL clavulanic acid was used, the MIC was 5, 1.5, 1 and > 300 µg/mL cefotaxime for Isolates I, II, III, and IV, respectively. This diversity in the treatment responses can be explained by the expression of different or additional types of Bla that exhibit different sensitivity to inhibition by clavulanic acid. For instance, isolates producing cephalosporinases or chromosomally mediated Bla have been shown to be poorly inhibited by clavulanic acid 31, 35, 36 . These results underscore a critical caveat in using predetermined formulations of β-lactam/Bla inhibitor combinations to combat ESBL-producing pathogens, which is currently a standard practice 31, 37, 38 . Given the diversity of the phenotypic responses by the different isolates, quantitative measurements on how a strain responds to an antibiotic and a Bla inhibitor are necessary to predict the outcome of a particular combination treatment.
Discussion
Resistance and resilience provide a powerful framework to dissect the contributions of different factors underlying a population's response to a disturbance. Despite their appeal, resistance and resilience have had limited applications due to differing definitions 1,2 and a lack of quantitative studies. Our analysis of an ESBL-producing clinical isolate's response to a β-lactam antibiotic serves as a concrete example that illustrates the dichotomy between resistance associated with single cells and resilience associated with populations. That is, resilience can be considered a cooperative trait by a group of bacteria (clonal or mixed).
Our work provides a concrete procedure to quantify resistance and resilience in a population (clonal or mixed) in response to neutral or negative perturbations, as both metrics can be uniquely defined from the time course of the population. As such, it can be applied to diverse situations. For example, some bacteria are resistant to xeric stress due to the disturbance triggering their adaptive mechanisms 39 . Specifically, a xerotolerant cell survives a dry spell by decreasing its energy consumption, protecting its DNA from damaging reactive oxygen species, stabilizing its membrane, and preventing intracellular water loss. Another example of resistance being a single cell level response is the production of heat-shock proteins to enable the cell's survival of stressful conditions, such as extreme temperatures 40, 41 . As for resilience, a population of cyanobacteria has been shown to depend on its density to survive high levels of light that are damaging to single cells. Mutual shading is a density dependent phenomenon achieved when the damaged cyanobacteria that are closer to the light source provide shade to their lower neighbors, thus allowing the population to regrow in lower, less damaging levels of light 42, 43 . Additionally, the microbiome is resilient to diet changes, antibiotic exposure and invasion by new species due to population level attributes such as species richness and function response diversity 44 .
In our analysis, the framework is applied to the dynamics of a homogenous population, where the resistance and resilience both depend on the average properties of cells. However, this framework is also applicable for dissecting bacterial responses to antibiotics for heterogeneous populations (Supplementary Fig. 7 ). In the extreme case, a population's antibiotic response can be driven by a small subpopulation of persisters, or slow-growing or dormant bacteria that are not sensitive to antibiotics 15, 45 . Upon antibiotic exposure, most of the population is killed, leaving the persisters behind. Once the antibiotic has been removed, the persisters, which are genetically identical to their sensitive counterparts, spontaneously switch back into the normal, growing state and reestablish the colony. This antibiotic response would be characterized with low resistance and high resilience due to the presence of persisters.
Alternatively, bacteria that have mutated forms of a given antibiotic's target are resistant to that antibiotic 46 . For instance, vancomycin-resistant Enterococcus faecalis (VRE) has mutated the end of a peptidoglycan strand, a component necessary for cell wall synthesis and the target for vancomycin 47 . This mutation reduces the peptidoglycan's binding affinity for vancomycin by 1000fold. Because a single bacterium of VRE has this mutation and ability to withstand much higher antibiotic concentrations, an entire population's antibiotic response would be characterized as high resistance.
Our framework is connected to another in quantifying bacterial responses. In particular,
Artemova and colleagues introduced the concept of single-cell minimal inhibitory concentration (scMIC) 48 to describe the susceptibility of individual bacteria to a β-lactam antibiotic 33 . This concept is in contrast to the concept of minimal inhibitory concentration (MIC), which is determined as the collective response of a population. The scMIC concept operates at the same level as resistance described in our study. Both reflect the ability of individual cells to survive an antibiotic except that resistance reflects the ability of an average cell. As a result, both depend on parameters associated with individual cells, including the maximum lysis rate. In contrast, resilience and MIC result from the collective behavior of the entire population. Both also depend on the inoculum size of the population, but resilience has the advantage of accounting for the temporal dynamics.
In addition to dissecting an antibiotic response into its components and corresponding attributes, the resistance-resilience framework has demonstrated the need to modulate combination treatments. Comparing the resistance-resilience fingerprint of different isolates under varied concentrations of cefotaxime and clavulanic acid revealed how varied their responses are to Bla inhibition. As one way to extend the efficacy of a β-lactam is by pairing it with a Bla inhibitor [49] [50] [51] , this observation is relevant for guiding the optimization of combination treatments. Currently, there are a few versions of the treatment combining clavulanic acid and amoxicillin for clinical use; however, the concentration of clavulanic acid is kept constant between the versions while the amoxicillin concentration is changed [52] [53] [54] . Early studies suggest this clavulanic acid concentration was selected to minimize patient side effects and maintain a sufficiently high serum concentration of clavulanic acid 31, 37, 38 . Nevertheless, our finding suggests that the clavulanic acid concentration can be optimized within a safe range to reduce the amount of antibiotic necessary and minimize the resistance and resilience of a given isolate. Furthermore, a recent study found that different ratios of inhibitor to antibiotic could influence the rate and mechanism of antibiotic resistance that bacteria develop 55 . Fig. 8 ) 1 mL overnight culture was washed (centrifuged for 5 minutes at 13000rpm, discarded supernatant, and resuspended in 1 mL fresh M9) and the optical density (OD) was adjusted to 0.5 OD600 by adding the appropriate volume of M9. The culture was then diluted 1000fold in fresh M9 and the appropriate amount of cefotaxime (Sigma) was added to achieve a range of concentrations from 0-300 µg/mL. A 96-well plate (Costar) was loaded with 200 µL of culture per well and topped with 50 µL mineral oil (Sigma) to prevent evaporation. The plate was loaded into a Tecan Infinite M200 PRO microplate reader (chamber temperature maintained at 30°C) and OD600 readings were measured every 10 minutes for 48 hours with intermittent plate shaking. Unless otherwise noted, each condition tested consisted of 4 technical
Methods
Bacterial strains, growth media, and culturing conditions:
Measuring time courses: (Supplementary
replicates that, when averaged, did not need to include error bars. Fig. 9 ) ESBL-producing Isolate I and sensitive strain MC4100 were cultured in M9 for 12 hours at 30°C. One mL of each overnight culture was washed (centrifuged for 5 minutes at 13000rpm, discarded supernatant, and resuspended in 1 mL fresh M9) and the OD was adjusted to 0.5 OD600 by adding the appropriate volume of M9. The culture was then diluted 1000fold in 4 mL of fresh M9
Cefotaxime activity level: (Supplementary
and the appropriate amount of cefotaxime was added to achieve final concentrations of 0, 10 or 100 µg/mL. The cultures were incubated at 37°C for 6 hours. At this time, lawns of sensitive cells were prepared by spreading 5 µL of the 1000fold diluted MC4100 culture onto agar plates. Supernatant from the cultures incubated with cefotaxime were prepared by spinning down 0.5 mL culture with 5 µg/mL clavulanic acid (to prevent further Bla activity). 4 µL of the supernatant were dropped into the center of the agar plates, which were then incubated for 16 hours at 37°C. The zones of inhibition were recorded by camera. Fig. 10 ) After conducting a 24-hour time course, as described in (2), culture that had been exposed to 0, 2 ug/mL, and 200 ug/mL of cefotaxime were diluted 10fold in fresh M9 (antibiotic free) and incubated at 37°C for 3
Selective pressure: (Supplementary
hours. The recovered cultures were then used to run another time course using the same antibiotic concentrations used in the previous round of treatment.
Quantifying
Bla activity: 1 mL overnight culture was washed (centrifuged for 5 minutes at 13000rpm, discarded supernatant, and resuspended in 1 mL fresh M9) and diluted 1000x in fresh M9. The appropriate amount of cefotaxime (Sigma) was added to achieve 0, 1, 10, and 100 µg/mL. The cultures were incubated for 3 hours at 30°C. For each culture, 1 mL was kept on ice to preserve the population density at the 3 hour time point. loaded into a Tecan Infinite M200 PRO microplate reader (chamber temperature maintained at 25°C) and OD600 and GFP readings were measured every 10 minutes for 1.5 hours. The GFP measurements of the samples were plotted over time and the slope was calculated. The slope was normalized by the whole cell's OD measurement.
Varying Bla inhibition:
The preparation of cells, antibiotic, and 96-well plate were prepared as in (2) . When the cefotaxime was added, clavulanic acid potassium salt (Sigma)
was also added to achieve final concentrations ranging from 0-5 µg/mL.
Varying initial cell density:
Culture was prepared as in (1) except culture dilution ranged from 100 to 100,000fold. Cultures were exposed to 0 or 100 µg/mL cefotaxime and time courses were measured by plate reader and the final cell density after 30 hours was recorded.
9. Plate reader data analysis: MATLAB (Version 9.2.0.556344, R2017a) was used to plot and characterize the time courses obtained from the plate reader (i.e. recovery time, growth rate, and change in GFP over time). d. Populations previously exposed to cefotaxime exhibited the same temporal dynamics.
Culture was treated with a range of antibiotic concentrations. After 24 hours, bacteria from the recovered population were used to re-inoculate fresh media with or without 25μg/mL cefotaxime.
During the 2 nd round of treatment, the time courses from the populations previously exposed to 0, 2, or 200 μg/mL cefotaxime were identical, suggesting that the population recovery was unlikely due to mutants or phenotypic variants with increased tolerance.
e. Bla production is not induced by cefotaxime. We used Fluorocillin to determine that the isolate's Bla production is not significantly increased by the addition of antibiotic. Here, the Bla activity present in a population after 3 hours of exposure to a range of antibiotic concentrations was quantified by the rate at which Fluorocillin was hydrolyzed and produced green fluorescence.
One way ANOVAs indicate that the increase in fluorescence recorded was insignificant when compared to the control. the treated population to reach the threshold ( 50% ). We characterized the population's resilience for a range of antibiotic concentrations as the inverse ratio of the times to the half maximal carrying capacity ( 0 50% / 50% ).
(B) Net growth rate quantifies population's resistance. When no antibiotic was added, the population's net growth rate decreased over time as it consumed the available nutrients and approached stationary phase. When a low dose of antibiotic was added, the net growth was not significantly altered (blue curve). In this instance, the treated population's maximum net growth rate is recorded as ρA and compared to the untreated population's net growth rate at the same time (ρ0). As the antibiotic concentration increased, the net growth rate curve of the treated population deviated more from the untreated curve. For each antibiotic concentration, ρA was recorded as the net growth rate at the point of maximum negative deviation from the untreated population and normalized by ρ0. We characterized a population's resistance as the ratio of recovery times (ρA/ρ0).
(C) Resistance and resilience as functions of the cefotaxime concentration. At low doses of cefotaxime, the population was resistant and resilient, showing little disturbance after exposure (see Fig. 2A-B) . As the antibiotic concentration was increased, resistance and resilience decreased due to the increase in cell lysis causing the net growth to decrease and the time to the half max density increased. Once the population underwent a crash, the resistance was minimized and resilience became the dominating factor for survival. as defined in (Fig. 4A) . The greyed lines indicate that the population recovered under all tested concentrations of cefotaxime tested at that concentration of clavulanic acid, therefore the MIC could not be calculated (Isolate I: clavulanic acid < 0.005 µg/mL; Isolate IV: clavulanic acid < 0.5 µg/mL).
